These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 3946146)

  • 1. Transient exacerbation followed by control of ventricular tachycardia with amiodarone.
    Mostow ND; Vrobel TR; Rakita L
    Am Heart J; 1986 Jan; 111(1):178-80. PubMed ID: 3946146
    [No Abstract]   [Full Text] [Related]  

  • 2. The efficacy of amiodarone for ventricular arrhythmias can be predicted with clinical electrophysiological studies.
    McGovern B; Ruskin JN
    Int J Cardiol; 1983 Apr; 3(1):71-6. PubMed ID: 6852993
    [No Abstract]   [Full Text] [Related]  

  • 3. Long-term clinical outcome of ventricular tachycardia or fibrillation treated with amiodarone.
    McGovern B; Garan H; Malacoff RF; DiMarco JP; Grant G; Sellers TD; Ruskin JN
    Am J Cardiol; 1984 Jun; 53(11):1558-63. PubMed ID: 6731300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical efficacy and electropharmacology of continuous intravenous amiodarone infusion and chronic oral amiodarone in refractory ventricular tachycardia.
    Saksena S; Rothbart ST; Shah Y; Cappello G
    Am J Cardiol; 1984 Aug; 54(3):347-52. PubMed ID: 6465016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical efficacy of intravenous amiodarone in the short term treatment of recurrent sustained ventricular tachycardia and ventricular fibrillation.
    Schützenberger W; Leisch F; Kerschner K; Harringer W; Herbinger W
    Br Heart J; 1989 Nov; 62(5):367-71. PubMed ID: 2590589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The efficacy of amiodarone for ventricular arrhythmias cannot be predicted with clinical electrophysiological studies.
    Waxman HL
    Int J Cardiol; 1983 Apr; 3(1):76-80. PubMed ID: 6852994
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical experience with amiodarone for treatment of recurrent ventricular tachycardia and ventricular fibrillation.
    Heger JJ; Prystowsky EN; Miles WM; Zipes DP
    Br J Clin Pract Suppl; 1986 Apr; 44():16-27. PubMed ID: 3089256
    [No Abstract]   [Full Text] [Related]  

  • 8. Amiodarone-induced ventricular fibrillation.
    McComb JM; Logan KR; Khan MM; Geddes JS; Adgey AA
    Eur J Cardiol; 1980; 11(5):381-5. PubMed ID: 7398728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High incidence of clinical and subclinical toxicity associated with amiodarone treatment of refractory tachyarrhythmias.
    Anastasiou-Nana MI; Anderson JL; Nanas JN; Lutz JR; Smith RA; Anderson KP; Crapo RO; Call NB
    Can J Cardiol; 1986; 2(3):138-45. PubMed ID: 2941121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical pharmacology of amiodarone.
    Marcus FI
    Ann N Y Acad Sci; 1984; 427():112-26. PubMed ID: 6378011
    [No Abstract]   [Full Text] [Related]  

  • 11. Amiodarone-induced refractoriness to cardioversion.
    Fogoros RN
    Ann Intern Med; 1984 May; 100(5):699-700. PubMed ID: 6712033
    [No Abstract]   [Full Text] [Related]  

  • 12. The efficacy of amiodarone in the treatment of ventricular tachycardia or ventricular fibrillation.
    Greene HL
    Prog Cardiovasc Dis; 1989; 31(5):319-54. PubMed ID: 2646655
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical efficacy and electrophysiology during long-term therapy for recurrent ventricular tachycardia or ventricular fibrillation.
    Heger JJ; Prystowsky EN; Jackman WM; Naccarelli GV; Warfel KA; Rinkenberger RL; Zipes DP
    N Engl J Med; 1981 Sep; 305(10):539-45. PubMed ID: 6789201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amiodarone-induced ventricular tachycardia.
    Westveer DC; Gadowski GA; Gordon S; Timmis GC
    Ann Intern Med; 1982 Oct; 97(4):561-2. PubMed ID: 7125414
    [No Abstract]   [Full Text] [Related]  

  • 15. Benefit and risks of long-term amiodarone therapy for sustained ventricular tachycardia/fibrillation: minimum of three-year follow-up in 145 patients.
    Myers M; Peter T; Weiss D; Nalos PC; Gang ES; Oseran DS; Mandel WJ
    Am Heart J; 1990 Jan; 119(1):8-14. PubMed ID: 2296879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term results of amiodarone therapy in patients with recurrent sustained ventricular tachycardia or ventricular fibrillation.
    Herre JM; Sauve MJ; Malone P; Griffin JC; Helmy I; Langberg JJ; Goldberg H; Scheinman MM
    J Am Coll Cardiol; 1989 Feb; 13(2):442-9. PubMed ID: 2913120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term treatment of ventricular tachycardia with amiodarone in presence of severe left ventricular dysfunction.
    Burckhardt D; Robertson A; Hoffmann A; Pfisterer M
    J Clin Pharmacol; 1991 Nov; 31(11):1105-8. PubMed ID: 1753016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of amiodarone on retrograde conduction and refractoriness of the His-Purkinje system in man.
    Reddy CP; Kuo CS
    Br Heart J; 1984 Jun; 51(6):648-53. PubMed ID: 6732994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Should oral amiodarone be used for sustained ventricular tachycardia in patients requiring open-heart surgery?
    MacKinnon G; Landymore R; Marble A
    Can J Surg; 1983 Jul; 26(4):355-7. PubMed ID: 6861030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of amiodarone in treatment of refractory atrial and ventricular tachyarrhythmias.
    Kato K
    Ann N Y Acad Sci; 1992 Jan; 644():235-45. PubMed ID: 1562118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.